Skip to content
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance […]
George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with an exclusive conversation with Biotechnology Innovation Organization (BIO) President & CEO
BIO 2025: A few highlights from Day 2 Read More »
Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key
BIO 2025: A few highlights from Day 1 Read More »
The 2025 BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), opens June 16 in Boston, bringing together over 20,000 industry leaders from
Welcome to BIO 2025: The world can’t wait. Read More »
Legislation introduced by Senators John Barrasso (R-WY) and Martin Heinrich (D-NM) would help protect the research and development of new treatments for patients with
Senators introduce bipartisan bill to protect new medicines for rare disease Read More »
The Food and Drug Administration (FDA) added to a small list of gene-edited animals that can be used in the food supply chain with
FDA approves pig genetically engineered to resist disease Read More »
Speaking on a recent Endpoints News panel, Nkarta CEO Paul Hastings discussed the impact of regulatory uncertainty and federal funding cuts on the investment
Nkarta’s Hastings discusses environment for biotech funding in Endpoints panel Read More »
Safeguarding human health during clinical research is critically important, but biotechnology has shown that this does not always have to mean using animals to
BIO report outlines use of NAMs to reduce animal testing Read More »
Now that vaccines have all but eliminated smallpox, measles, polio, and other childhood scourges in the U.S., it seems easy to forget that these
BIO campaign urges: ‘Invest in America. Vaccinate’ Read More »
While gene editing holds great promise for helping animals withstand disease, regulatory burdens and barriers to commercialization keep us from realizing its full potential,
BIO promotes regulatory and market uptake of biotech for animals in Dallas Read More »
